Back to UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

RPRXRPRX
Showing 8 of 21 quarters

Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ROYALTY PHARMA PLC

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 3.1M shares of RPRX (ROYALTY PHARMA PLC), worth $148.5M as of 2026-Q1. The position was decreased (-0.7% shares). RPRX represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.

Current Value

$148.5M

Current Shares

3.1M

Total Value Change

+$74.7M

Total Shares Change

+298,439

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
3.1M
-0.7%
$148.5M0.0%$47.48
0
2025-Q4
Decreased
3.1M
-0.3%
$120.5M0.0%$38.99
0
2025-Q3
Decreased
3.1M
-23.2%
$110.4M0.0%$35.05
0
2025-Q2
Increased
4.1M
+43.2%
$146.9M0.0%$35.46
41
2025-Q1
Increased
2.8M
+8.6%
$88.7M0.0%$30.80
32
2024-Q4
Decreased
2.6M
-11.8%
$66.9M0.0%$24.70
0
2024-Q3
Increased
3M
+6.3%
$84.1M0.0%$27.29
32
2024-Q2
Increased
2.8M
+50.1%
$73.8M0.0%$25.32
41

Other major holders of RPRX: ADAGE CAPITAL PARTNERS GP, L.L.C., MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used